Unapproved drugs still sold
Patient Access Weekly Advisor, November 26, 2008
Want to receive articles like this one in your inbox? Subscribe to Patient Access Weekly Advisor!
Medicaid still covers drugs not reviewed by the government ? about $200 million worth since 2004, the Associated Press reports.
The medications ? linked to dozens of deaths ? are decades old. The Food and Drug Administration had less restrictive measures then and has tried, to no avail, to eliminate them from the market.
Get the full story in the Associated Press.
Want to receive articles like this one in your inbox? Subscribe to Patient Access Weekly Advisor!
Comments
0 comments on “Unapproved drugs still sold ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- Q/A: Coding for telescopic intraocular lens
- What does case-mix index mean to you?
- Q&A: Incidental disclosures and patient privacy
- HIPAA 5010 deadline extended, but threat remains, says AMA
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Tip: Correctly code bilateral pain management procedures
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Documentation and coding for toxic metabolic encephalopathy
- Guidance and tact key to compliant, effective physician queries
- Searched
